The effect of in vivo deprenyl on cerebral amine system in rats with portocaval shunts.
Fogel
W A
WA
Polish Academy of Sciences, Institute of Biogenic Amines, Lodz. wafogel@mazurek.man.lodz.pl
Andrzejewski
W
W
Sasiak
K
K
Maslinski
C
C
D000818:Animals; D015306:Biogenic Monoamines / Q000378:metabolism*; D001921:Brain / Q000187:drug effects* / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006632:Histamine / Q000378:metabolism; D006897:Hydroxyindoleacetic Acid / Q000378:metabolism; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology*; D009638:Norepinephrine / Q000378:metabolism; D011167:Portacaval Shunt, Surgical; D051381:Rats; D012642:Selegiline / Q000494:pharmacology*; D012701:Serotonin / Q000378:metabolism
D015306:Biogenic Monoamines; D008996:Monoamine Oxidase Inhibitors; D012642:Selegiline; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D006632:Histamine; D008995:Monoamine Oxidase; D004298:Dopamine; D009638:Norepinephrine